EFPIA companies and public partners join up to improve health data eco-system in Europe

Today, in Europe, we are challenged to generate insights and evidence from real world clinical data at scale, to support patients, clinicians, payers, regulators, governments, and the pharmaceutical industry in understanding wellbeing, disease, treatments, outcomes and new therapeutics and devices. Unfortunately, such data is difficult to use at scale, in a myriad of languages, systems and structures, with challenging policy restrictions and technology considerations.

In response to this, the EHDEN public private project was set up under the framework of the Innovative Medicines Initiative, co-funded by EFPIA and the European Commission, with twenty-two partners, including academia, SMEs, patient associations, regulatory authorities and pharmaceutical companies. The project is led by Erasmus Medical Centre, The Netherlands, and Janssen Pharmaceutica N.V., Belgium. The mission of EHDEN is to provide a new paradigm for the discovery and analysis of health data in Europe, by building a large-scale, federated network of data sources standardised to a common data model. EHDEN’s aspirations are significant, aiming to harmonise 100 million, anonymised health records across multiple data sources.
"The transition to more outcomes-based and sustainable healthcare in Europe requires better use of health data", said EFPIA Director-General Nathalie Moll. "The EHDEN project is a significant step in creating the necessary health data environment in Europe to realise this goal, and the scale and ambition of this undertaking shows the impact that the pharmaceutical industry and public stakeholders can have when they work together towards common objectives."
The full press release from EHDEN can be found here.